| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/03/2011 | WO2011065982A2 Polymorphisms associated with parkinson's disease |
| 06/03/2011 | WO2011065905A1 Solid forms of 4-{(r)-(3-aminophenyl)[4-(4-fluorobenzyl)-piperazin-1-yl]methyl}-n,n-diethylbenzamide, compositions thereof, and uses therewith |
| 06/03/2011 | WO2011065880A1 Dietary fibre composition containing beta-glucan |
| 06/03/2011 | WO2011065831A2 Improved formulations comprising heteropolysaccharides |
| 06/03/2011 | WO2011065800A2 Pyrimidine derivative, method for preparing same and pharmaceutical composition containing same |
| 06/03/2011 | WO2011065677A2 Pharmaceutical composition for treating cancer |
| 06/03/2011 | WO2011065658A2 Method for extracting glyceollins for use in functional whitening preparations |
| 06/03/2011 | WO2011065552A1 Nutritional composition beneficial to small intestine |
| 06/03/2011 | WO2011065545A1 5-FLUOROURACIL COMPOUND HAVING dUTPase-INHIBITING ACTIVITY OR SALT THEREOF |
| 06/03/2011 | WO2011065541A1 Anti-tumor effect potentiator |
| 06/03/2011 | WO2011065519A1 Substituted oxopiperazine compound |
| 06/03/2011 | WO2011065480A1 Nerve cell death inhibitor |
| 06/03/2011 | WO2011065444A1 Antithrombotic agent |
| 06/03/2011 | WO2011065420A1 Method for manufacturing a 6-substituted-1-methyl-1h-benzimidazole derivative, and manufacturing intermediate from said method |
| 06/03/2011 | WO2011065402A1 Indole compound and pharmaceutical use thereof |
| 06/03/2011 | WO2011065300A1 Antiviral agent and food/beverage composition |
| 06/03/2011 | WO2011064793A1 Process for the preparation of amorphous valganciclovir hydrochloride |
| 06/03/2011 | WO2011064769A1 Methods and pharmaceutical compositions for the treatment of hot flashes |
| 06/03/2011 | WO2011064755A1 Compositions comprising amino acids for treating chronic obstructive pulmonary disease |
| 06/03/2011 | WO2011064753A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 06/03/2011 | WO2011064743A1 Acrylic or methacrylic polymer including alpha-tocopherol grafts |
| 06/03/2011 | WO2011064710A1 In vitro anti-sickling activity of betulinic acid, oleanolic acid and their derivatives |
| 06/03/2011 | WO2011064663A1 Combination treatment employing belinostat and bicalutamide |
| 06/03/2011 | WO2011064661A1 Small pyrimidine derivatives and methods of use thereof |
| 06/03/2011 | WO2011064657A2 Quinazolin-4(3a)-one derivatives and methods of use thereof |
| 06/03/2011 | WO2011064574A1 Hplc method for detecting lenalidomide |
| 06/03/2011 | WO2011064559A2 Novel inositol phosphate derivatives |
| 06/03/2011 | WO2011064547A1 Inhibition of pancreatic lipase |
| 06/03/2011 | WO2011064524A1 Dermatological compositions comprising a fat or oil of an essential fatty acid triglyceride |
| 06/03/2011 | WO2011064508A1 Use of a dipyridyl compound for treating rosacea |
| 06/03/2011 | WO2011064474A1 Pharmaceutical composition containing strontium salt, vitamin d, and cyclodextrin |
| 06/03/2011 | WO2011064395A2 Inhibitors and antagonists of calcium channels in the treatment of asthma |
| 06/03/2011 | WO2011064376A1 Imidazole derivatives as aldosterone synthase inhibitors |
| 06/03/2011 | WO2011064352A1 Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin |
| 06/03/2011 | WO2011064350A1 Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
| 06/03/2011 | WO2011064328A1 Triazolopyridine derivatives |
| 06/03/2011 | WO2011064315A1 4-[2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine salts |
| 06/03/2011 | WO2011064303A1 Sialochimeric compounds |
| 06/03/2011 | WO2011064300A1 Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions |
| 06/03/2011 | WO2011064297A1 Combination for the treatment of radiation - or chemotherapy - induced mucositis |
| 06/03/2011 | WO2011064296A1 Pharmaceutical compositions comprising sigma receptor ligands |
| 06/03/2011 | WO2011064288A1 Morpholinothiazoles as alpha 7 positive allosteric modulators |
| 06/03/2011 | WO2011064274A1 Use of h3 histaminergic agonists for the treatment of addiction to drugs of abuse |
| 06/03/2011 | WO2011064271A2 Use of an oleo gel containing triterpene for healing wounds |
| 06/03/2011 | WO2011064256A1 A new crystalline form of pemetrexed disodium |
| 06/03/2011 | WO2011064254A1 Use of a vaccine against the vzv/hsv3 virus for treating hsv1 and/or hsv2 herpes virus infections |
| 06/03/2011 | WO2011064250A1 Novel naphthyridine derivatives and the use thereof as kinase inhibitors |
| 06/03/2011 | WO2011064237A1 Crystalline forms of substituted pyrazolopyrimidines |
| 06/03/2011 | WO2011064216A1 Novel salts of rasagiline |
| 06/03/2011 | WO2011064211A1 Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroaryls |
| 06/03/2011 | WO2011064189A1 Novel polymorphic shapes of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-5-yl)carbamate |
| 06/03/2011 | WO2011064152A1 Inhibitors of topoisomerase i for the treatment of autoimmune diseases |
| 06/03/2011 | WO2011064141A1 Sultam derivatives |
| 06/03/2011 | WO2011064130A1 Pharmaceutical composition comprising mirna-100 and its use in the modulation of blood vessel growth and endothelial inflammation |
| 06/03/2011 | WO2011064111A1 Film-like pharmaceutical dosage forms |
| 06/03/2011 | WO2011063915A1 Liquid pharmaceutical compositions |
| 06/03/2011 | WO2011063908A1 Triazolopyridines |
| 06/03/2011 | WO2011063907A1 Substituted triazolopyridines |
| 06/03/2011 | WO2011063774A2 Pectin complexes of steroids and pharmaceutical compositions based thereon |
| 06/03/2011 | WO2011063764A1 Azilsartan organic amine salts, preparation method and use thereof |
| 06/03/2011 | WO2011063732A1 Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof |
| 06/03/2011 | WO2011063615A1 Macrocyclic amides, pharmaceutical compositions, preparation methods and uses thereof |
| 06/03/2011 | WO2011063606A1 Ophthalmic gel of gatifloxacin and preparation method thereof |
| 06/03/2011 | WO2011063605A1 Compound / glucose preparation |
| 06/03/2011 | WO2011063604A1 Compound / sodium chloride preparation |
| 06/03/2011 | WO2011063602A1 Use of 5-substituted-2, 4-thiazolidinediones in preparation of medicaments for modulating insulin-like growth factor 1 receptor |
| 06/03/2011 | WO2011063595A1 Depolymerized glycosaminoglycan from thelenota ananas and preparation method thereof |
| 06/03/2011 | WO2011063531A1 Topical ibuprofen formulations |
| 06/03/2011 | WO2011063502A1 Hepatitis c inhibitor compounds |
| 06/03/2011 | WO2011063501A1 Hepatitis c inhibitor compounds |
| 06/03/2011 | WO2011063456A1 Methods and compositions for increasing sensitivity to tyrosine kinase inhibitors |
| 06/03/2011 | WO2011063455A1 Modulation of epidermal growth factor receptor ligands |
| 06/03/2011 | WO2011044506A3 Sulphone compounds for use in the treatment of obesity |
| 06/03/2011 | WO2011044375A3 Apogossypolone derivatives as anticancer agents |
| 06/03/2011 | WO2011043962A3 Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof |
| 06/03/2011 | WO2011042918A3 Improved processes for preparing prasugrel and pharmaceutically acceptable salts thereof |
| 06/03/2011 | WO2011042890A3 Use of phenolic compounds for protein deglycolysation |
| 06/03/2011 | WO2011042860A3 New derivatives of thieno[2,3-b]pyridine and 5,6,7,8-tetrahydrothieno[2,3-b]quinoline in particular useful in the treatment of malaria |
| 06/03/2011 | WO2011042565A3 Antiprotozoal activity of an efflux inhibitor with an anti-protozoal drug |
| 06/03/2011 | WO2011042473A3 Estrogen receptor ligands |
| 06/03/2011 | WO2011041579A3 (20S,22E)-2-METHYLENE-19-NOR-22-ENE-1α,25-DIHYDROXYVITAMIN D3 ANALOGS |
| 06/03/2011 | WO2011041146A3 Dosage regimen of an s1p receptor modulator |
| 06/03/2011 | WO2011041145A3 Method and system for accessing patient data |
| 06/03/2011 | WO2011033225A3 Substituted 3-amino-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 06/03/2011 | WO2011031601A3 Nutritional compositions including exogenous vitamin k2 |
| 06/03/2011 | WO2011030332A3 Methods for hematopoietic precursor mobilization |
| 06/03/2011 | WO2011028416A3 Oral medication for the treatment of hemorrhoids and method of use |
| 06/03/2011 | WO2011024168A3 Sustained release delivery systems for the prevention and treatment of head and neck cancers |
| 06/03/2011 | WO2011019630A3 Treatment of brain metastases with inhibitors of endothelin receptors in combination with a cytotoxic chemotherapy agent |
| 06/03/2011 | WO2011017483A3 Sublingual and buccal film compositions |
| 06/03/2011 | WO2011017108A3 Cyclopropyl modulators of p2y12 receptor |
| 06/03/2011 | WO2011017054A3 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 06/03/2011 | WO2011014795A3 Compounds and compositions as syk kinase inhibitors |
| 06/03/2011 | WO2011014613A3 Preparation of fipamezole |
| 06/03/2011 | WO2011008572A3 5-ht3 receptor modulators, methods of making, and use thereof |
| 06/03/2011 | WO2011007230A3 Lupeol-type triterpene derivatives as antivirals |
| 06/03/2011 | WO2010135429A8 Compositions for modulating a kinase cascade and methods of use thereof |
| 06/03/2011 | WO2010103544A4 A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants |
| 06/03/2011 | WO2010100381A9 Novel antiviral agent |
| 06/03/2011 | WO2010077925A3 Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate |